BioSkryb Genomics and Tecan Group, today introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit ...

A new drug combination shows promise for colon cancer patients whose disease no longer responds to standard chemotherapy ...

uGDB, utilizing next-generation sequencing to detect bladder cancer-associated mutations and DNA alterations, has previously shown associations with recurrence and therapy response.

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in ...

Russian-born scientist Kseniia Petrova never imagined she would face significant immigration issues, but it has been 68 days ...

This symptom when going to the toilet can be a sign of prostate, bladder or kidney cancer and should "never be ignored".

Highlights include work focused on AI, precision medicine, immunotherapies and more LOS ANGELES--(BUSINESS WIRE)--Researchers with City of Hope®, one of the largest and most advanced cancer research ...

Kseniia Petrova never imagined she would face significant immigration issues, but it has been 68 days since she was detained ...